2013
DOI: 10.1016/j.ophtha.2012.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Visual Outcome, Treatment Results, and Prognostic Factors in Patients with Scleritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
59
0
3

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(65 citation statements)
references
References 27 publications
3
59
0
3
Order By: Relevance
“…Significantly higher rates of ocular complications and disease association were reported by Sainz de la Maza et al 5 Their study reported ocular complications in 19% of patients with episcleritis and 45% of patients with scleritis, including uveitis (16.5% and 26.4%, respectively). In the study by Wieringa et al, 7 88 patients (84.6%) had ocular complications indicating a high frequency of the occurrence of ocular complications associated with ocular inflammatory disease, such as scleritis. Similar to systemic disease associations, the rates of ocular complications in this study are likely less because of referral bias in the studies published before this one.…”
Section: Discussionmentioning
confidence: 93%
“…Significantly higher rates of ocular complications and disease association were reported by Sainz de la Maza et al 5 Their study reported ocular complications in 19% of patients with episcleritis and 45% of patients with scleritis, including uveitis (16.5% and 26.4%, respectively). In the study by Wieringa et al, 7 88 patients (84.6%) had ocular complications indicating a high frequency of the occurrence of ocular complications associated with ocular inflammatory disease, such as scleritis. Similar to systemic disease associations, the rates of ocular complications in this study are likely less because of referral bias in the studies published before this one.…”
Section: Discussionmentioning
confidence: 93%
“…It is a common misconception that the presence of an ocular manifestation in the absence of systemic manifestations represents a quiet disease. It should be noticed that ocular manifestations, particularly necrotizing scleritis, can be an indicator for both morbidity and mortality unless appropriate systemic treatment is initiated (37,75).…”
Section: Systemic Treatmentmentioning
confidence: 99%
“…With regard to the latter two points, the importance of a comprehensive clinical work-up for each of these patients cannot be overstated. Necessity, urgency, and safety of treatment are dependent upon these three points and are critically important in treatment success and prevention of ocular and drug-related complications [6,7]. Secondary points may include the relief of symptoms and the maintenance of quality of life for the patient, which can be bankrupt by inflammatory flare-ups [7].…”
Section: Other Important Considerationsmentioning
confidence: 99%